Skip to content

2023 Women's Venture Competition

The AIM-HI Accelerator Fund congratulates our six semi-finalists led by six aspiring women scientist-entrepreneurs. The winning early-stage oncology company of 2023 Women’s Venture Competition will receive up to $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Our Semi-Finalists

Li-Fen Lee

Li-Fen Lee, Ph.D.
CEO & Founder

APEXimmune Tx
Lily_Zou

Lily Zou, Ph.D., MBA
CEO & Co-Founder

Degron_Therapeutics
Liza_Delee

Liza Velarde
Co-Founder, CEO & Director

Delee
Sarah_Hein

Sarah Hein, Ph.D.
Co-Founder & CEO

March Bio
Wassana Yantasee

Wassana Yantasee, Ph.D., MBA
CEO & Director

PDX pharma
tin tin su

Tin Tin Su, Ph.D.
CSO & Co-Founder

Suvica

The AIM-HI Accelerator Fund congratulates our six semi-finalists led by six aspiring women scientist-entrepreneurs. The winning early-stage oncology company of 2023 Women’s Venture Competition will receive up to $1 million in investment from AIM-HI and co-investors, subject to due diligence and negotiation. which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

In addition, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition …  but we can ALL Cast our Vote! 

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Back To Top